• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素制剂提高生物利用度的药代动力学研究及批判性重新评估。

A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability.

作者信息

Kroon Maurice A G M, van Laarhoven Hanneke W M, Swart Eleonora L, van Tellingen Olaf, Kemper E Marleen

机构信息

Department of Pharmacy and Clinical Pharmacology, Amsterdam University Medical Center, AMC, 1105AZ Amsterdam, the Netherlands.

Department of Medical Oncology, Amsterdam University Medical Center, University of Amsterdam, 1081HV Amsterdam, the Netherlands.

出版信息

iScience. 2025 May 3;28(6):112575. doi: 10.1016/j.isci.2025.112575. eCollection 2025 Jun 20.

DOI:10.1016/j.isci.2025.112575
PMID:40487425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12144411/
Abstract

This independent crossover study assessed curcumin bioavailability and excretion in nine healthy males receiving three formulations (AOV, Longvida, and NovaSOL) at about 570 mg, while AOV was also tested at 2280 mg, with and without piperine. Plasma levels of unconjugated curcumin remained below 2 nM in most cases, including high-dose AOV and piperine combinations. NovaSOL achieved the highest levels (6.7-38 nM at 30 min), but these rapidly declined and were still 100-fold lower than concentrations used to show biological effects. Curcumin conjugates exceeded 10 nM with all formulations, particularly NovaSOL, which showed 100-fold higher levels. Fecal recovery mainly included unconjugated curcuminoids and was high, except for NovaSOL, suggesting better intestinal absorption. However, even when using a formulation with enhanced uptake, plasma levels of unconjugated curcumin remained minimal. Piperine addition provided no benefit. The findings underscore that bioavailability claims should be based on unconjugated curcumin and not on its poorly membrane permeable conjugates.

摘要

这项独立交叉研究评估了9名健康男性在服用三种约570毫克制剂(AOV、Longvida和NovaSOL)时姜黄素的生物利用度和排泄情况,同时还对2280毫克的AOV进行了测试,测试时添加或不添加胡椒碱。在大多数情况下,包括高剂量AOV与胡椒碱联合使用时,未结合姜黄素的血浆水平仍低于2纳摩尔。NovaSOL达到了最高水平(30分钟时为6.7 - 38纳摩尔),但这些水平迅速下降,仍比显示生物学效应所用的浓度低100倍。所有制剂的姜黄素结合物均超过10纳摩尔,特别是NovaSOL,其水平高出100倍。粪便回收率主要包括未结合的姜黄素类化合物,除NovaSOL外回收率较高,这表明肠道吸收较好。然而,即使使用具有增强摄取作用的制剂,未结合姜黄素的血浆水平仍然很低。添加胡椒碱并无益处。这些发现强调,生物利用度的说法应以未结合的姜黄素为依据,而不是以其膜通透性差的结合物为依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/cbe2a2f82865/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/0ec3e12bc591/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/1b28ffc6ce7d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/2c3f011d622c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/527b6b85ccf8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/cbe2a2f82865/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/0ec3e12bc591/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/1b28ffc6ce7d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/2c3f011d622c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/527b6b85ccf8/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f74/12144411/cbe2a2f82865/gr4.jpg

相似文献

1
A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability.姜黄素制剂提高生物利用度的药代动力学研究及批判性重新评估。
iScience. 2025 May 3;28(6):112575. doi: 10.1016/j.isci.2025.112575. eCollection 2025 Jun 20.
2
Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers.生物利用度可的姜黄素制剂:健康志愿者药代动力学研究综述。
J Integr Med. 2018 Nov;16(6):367-374. doi: 10.1016/j.joim.2018.07.001. Epub 2018 Jul 4.
3
Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study.姜黄素类单剂量的药代动力学取决于配方:一项人体交叉研究的结果。
J Nutr. 2021 Jul 1;151(7):1802-1816. doi: 10.1093/jn/nxab087.
4
Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers.姜黄素和胡椒碱草药提取物对健康志愿者中咪达唑仑、氟比洛芬和对乙酰氨基酚(扑热息痛)药代动力学的影响。
Br J Clin Pharmacol. 2013 Feb;75(2):450-62. doi: 10.1111/j.1365-2125.2012.04364.x.
5
No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controls.与对照组相比,经淀粉样蛋白证实的阿尔茨海默病(AD)患者口服姜黄素后视网膜荧光无差异。
Alzheimers Dement (Amst). 2022 Aug 15;14(1):e12347. doi: 10.1002/dad2.12347. eCollection 2022.
6
Non-therapeutic plasma levels in individuals utilizing curcumin supplements in daily life.在日常生活中使用姜黄素补充剂的个体中的非治疗性血浆水平。
Front Nutr. 2023 Nov 30;10:1267035. doi: 10.3389/fnut.2023.1267035. eCollection 2023.
7
Bioavailability of a Sustained Release Formulation of Curcumin.姜黄素缓释制剂的生物利用度。
Integr Med (Encinitas). 2014 Jun;13(3):24-30.
8
Isocratic high-performance liquid chromatography (HPLC) for simultaneous quantification of curcumin and piperine in a microparticle formulation containing and .等度高效液相色谱法(HPLC)用于同时定量含有[具体成分1]和[具体成分2]的微粒制剂中的姜黄素和胡椒碱。
Heliyon. 2021 Mar 24;7(3):e06541. doi: 10.1016/j.heliyon.2021.e06541. eCollection 2021 Mar.
9
Randomized Pharmacokinetic Crossover Study Comparing 2 Curcumin Preparations in Plasma and Rectal Tissue of Healthy Human Volunteers.在健康人类志愿者的血浆和直肠组织中比较两种姜黄素制剂的随机药代动力学交叉研究。
J Clin Pharmacol. 2017 Feb;57(2):185-193. doi: 10.1002/jcph.806. Epub 2016 Sep 6.
10
Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects.分析不同姜黄素创新配方,以提高人体的相对口服生物利用度。
Eur J Nutr. 2018 Apr;57(3):929-938. doi: 10.1007/s00394-016-1376-9. Epub 2017 Feb 16.

本文引用的文献

1
The role of tetrahydrocurcumin in disease prevention and treatment.四氢姜黄素在疾病防治中的作用。
Food Funct. 2024 Jul 1;15(13):6798-6824. doi: 10.1039/d3fo05739a.
2
Non-therapeutic plasma levels in individuals utilizing curcumin supplements in daily life.在日常生活中使用姜黄素补充剂的个体中的非治疗性血浆水平。
Front Nutr. 2023 Nov 30;10:1267035. doi: 10.3389/fnut.2023.1267035. eCollection 2023.
3
Clinical trials on curcumin in relation to its bioavailability and effect on malignant diseases: critical analysis.关于姜黄素生物利用度及其对恶性疾病影响的临床试验:批判性分析。
Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):3477-3491. doi: 10.1007/s00210-023-02825-7. Epub 2023 Nov 15.
4
Therapeutic potential and limitations of curcumin as antimetastatic agent.姜黄素作为抗转移剂的治疗潜力和局限性。
Biomed Pharmacother. 2023 Jul;163:114758. doi: 10.1016/j.biopha.2023.114758. Epub 2023 May 2.
5
A validated HPLC-MS/MS method for simultaneously analyzing curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or feces.一种经过验证的高效液相色谱-串联质谱法,用于同时分析人血浆、尿液或粪便中的姜黄素、去甲氧基姜黄素、双去甲氧基姜黄素、四氢姜黄素和胡椒碱。
Heliyon. 2023 Apr 20;9(5):e15540. doi: 10.1016/j.heliyon.2023.e15540. eCollection 2023 May.
6
A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health.姜黄素在人类健康方面的益处和问题的综合综述。
Molecules. 2022 Jul 8;27(14):4400. doi: 10.3390/molecules27144400.
7
Increasing Post-Digestive Solubility of Curcumin Is the Most Successful Strategy to Improve its Oral Bioavailability: A Randomized Cross-Over Trial in Healthy Adults and In Vitro Bioaccessibility Experiments.提高姜黄素的餐后溶解性是改善其口服生物利用度最成功的策略:一项在健康成年人中进行的随机交叉试验和体外生物利用度实验。
Mol Nutr Food Res. 2021 Dec;65(24):e2100613. doi: 10.1002/mnfr.202100613. Epub 2021 Nov 1.
8
Pharmacokinetics of a Single Dose of Turmeric Curcuminoids Depends on Formulation: Results of a Human Crossover Study.姜黄素类单剂量的药代动力学取决于配方:一项人体交叉研究的结果。
J Nutr. 2021 Jul 1;151(7):1802-1816. doi: 10.1093/jn/nxab087.
9
Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study.新型生物增强型姜黄素联合美沙拉嗪治疗轻中度溃疡性结肠炎的诱导缓解:一项随机双盲安慰剂对照的初步研究。
J Clin Gastroenterol. 2021 Sep 1;55(8):702-708. doi: 10.1097/MCG.0000000000001416.
10
The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.姜黄素作为溃疡性结肠炎补充疗法的应用:随机对照临床试验的系统评价。
Nutrients. 2020 Jul 31;12(8):2296. doi: 10.3390/nu12082296.